SG160424A1 - Compositions of influenza viral proteins and methods of use thereof - Google Patents
Compositions of influenza viral proteins and methods of use thereofInfo
- Publication number
- SG160424A1 SG160424A1 SG201001924-8A SG2010019248A SG160424A1 SG 160424 A1 SG160424 A1 SG 160424A1 SG 2010019248 A SG2010019248 A SG 2010019248A SG 160424 A1 SG160424 A1 SG 160424A1
- Authority
- SG
- Singapore
- Prior art keywords
- compositions
- methods
- influenza viral
- viral proteins
- fusion proteins
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 3
- 206010022000 influenza Diseases 0.000 title abstract 2
- 108010067390 Viral Proteins Proteins 0.000 title 1
- 102000037865 fusion proteins Human genes 0.000 abstract 2
- 108020001507 fusion proteins Proteins 0.000 abstract 2
- 229920001184 polypeptide Polymers 0.000 abstract 2
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 2
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 2
- 102000018697 Membrane Proteins Human genes 0.000 abstract 1
- 108010052285 Membrane Proteins Proteins 0.000 abstract 1
- 239000000427 antigen Substances 0.000 abstract 1
- 102000036639 antigens Human genes 0.000 abstract 1
- 108091007433 antigens Proteins 0.000 abstract 1
- 230000028993 immune response Effects 0.000 abstract 1
- 244000052769 pathogen Species 0.000 abstract 1
- 230000001717 pathogenic effect Effects 0.000 abstract 1
- 230000003612 virological effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6031—Proteins
- A61K2039/6075—Viral proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6093—Synthetic polymers, e.g. polyethyleneglycol [PEG], Polymers or copolymers of (D) glutamate and (D) lysine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
- C07K2319/74—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Virology (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Molecular Biology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Communicable Diseases (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oncology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US63825404P | 2004-12-21 | 2004-12-21 | |
| US63835004P | 2004-12-21 | 2004-12-21 | |
| US64506705P | 2005-01-19 | 2005-01-19 | |
| US65320705P | 2005-02-15 | 2005-02-15 | |
| US66687805P | 2005-03-31 | 2005-03-31 | |
| US68207705P | 2005-05-18 | 2005-05-18 | |
| US74120205P | 2005-11-30 | 2005-11-30 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG160424A1 true SG160424A1 (en) | 2010-04-29 |
Family
ID=36272492
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG201001924-8A SG160424A1 (en) | 2004-12-21 | 2005-12-21 | Compositions of influenza viral proteins and methods of use thereof |
Country Status (9)
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2006206647C1 (en) * | 2005-01-19 | 2011-01-20 | Vaxinnate Corporation | Compositions comprising pathogen-associated molecular patterns and antigens and their use to stimulate an immune response |
| CN106237316A (zh) | 2006-03-07 | 2016-12-21 | 法克斯因内特公司 | 包含血细胞凝集素的组合物、制造其的方法与使用其的方法 |
| US20100068224A1 (en) * | 2006-04-24 | 2010-03-18 | Roberto Crea | Method for Producing Viral Vaccine and Therapeutic Peptide Antigens |
| EP2857038B1 (en) * | 2006-09-18 | 2019-04-10 | The Board of Trustees of the University of Arkansas | Compositions and methods of enhancing immune responses |
| EP1925318A1 (en) * | 2006-11-20 | 2008-05-28 | Paul-Ehrlich-Institut | Recombinant modified vaccinia virus Ankara (MVA)-based vaccine for the avian flu |
| WO2008157419A2 (en) * | 2007-06-13 | 2008-12-24 | The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Immunogenic peptides of influenza virus |
| CA2695399C (en) | 2007-08-02 | 2017-10-17 | Biondvax Pharmaceuticals Ltd. | Multimeric multiepitope influenza vaccines |
| GB0720250D0 (en) | 2007-10-17 | 2007-11-28 | Univ Edinburgh | Immunogenic compositions containing escherichia coli h7 flagella and methods of use thereof |
| WO2009062348A1 (fr) * | 2007-11-14 | 2009-05-22 | Institute Of Microbiology, Chinese Academy Of Sciences | Procédés d'inhibition d'une infection par le virus de la grippe et leurs médicaments |
| WO2009128950A2 (en) | 2008-04-18 | 2009-10-22 | Vaxinnate Corporation | Deletion mutants of flagellin and methods of use |
| WO2010115229A1 (en) | 2009-04-09 | 2010-10-14 | The University Of Melbourne | Immunogenic composition and uses thereof |
| MX348663B (es) * | 2009-09-08 | 2017-05-26 | Inst Tecnologico Estudios Superiores Monterrey | Proceso de producción de una vacuna recombinante, dicha vacuna expresable en cepas de escherichia coli y su uso para combatir la influenza a h1ni1 brote 2009. |
| JP2013516469A (ja) * | 2010-01-06 | 2013-05-13 | ヴァクシネイト コーポレイション | 高齢者に保護免疫を提供するための方法及び組成物 |
| JP6242050B2 (ja) | 2010-01-21 | 2017-12-06 | ザ ボード オブ トラスティーズ オブ ザ ユニバーシティ オブ アーカンソー | 免疫応答を増強するワクチンベクターおよび方法 |
| JP2013523096A (ja) * | 2010-03-26 | 2013-06-17 | エマージェント プロダクト デベロップメント ゲイザーズバーグ インコーポレイテッド | インフルエンザマトリックス２タンパク質の外部ドメイン、発現システムおよびそれらの使用 |
| GB201009273D0 (en) * | 2010-06-03 | 2010-07-21 | Glaxosmithkline Biolog Sa | Novel vaccine |
| WO2012037612A1 (en) | 2010-09-22 | 2012-03-29 | The University Of Melbourne | Novel immunostimulatory method |
| AU2011360572B2 (en) | 2011-02-22 | 2017-03-02 | Biondvax Pharmaceuticals Ltd. | Multimeric multiepitope polypeptides in improved seasonal and pandemic influenza vaccines |
| US8932598B2 (en) | 2012-08-28 | 2015-01-13 | Vaxinnate Corporation | Fusion proteins and methods of use |
| EP2914283B1 (en) * | 2012-11-05 | 2020-05-20 | Georgia State University Research Foundation, Inc. | Universal influenza vaccine based on heterologous multiple m2e proteins |
| RU2571944C1 (ru) * | 2014-10-17 | 2015-12-27 | Общество с ограниченной ответственностью "НТфарма" | Противогриппозная вакцина широкого спектра действия против птичьего гриппа а на основе эктодомена белка м2 |
| CA3085377A1 (en) | 2017-12-21 | 2019-06-27 | Ena Therapeutics Pty Ltd | Optimised compounds |
| CA3142501A1 (en) | 2019-06-26 | 2020-12-30 | Axelia Oncology Pty Ltd | Novel molecules |
| EP4395762A1 (en) * | 2021-09-02 | 2024-07-10 | Ena Respiratory Pty Ltd | Formulation |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1688606B (zh) * | 2002-08-12 | 2013-12-25 | 昆士兰医学研究所理事会 | 含有辅助t细胞和b细胞表位的新的免疫原性脂肽 |
| US20040223976A1 (en) * | 2003-03-07 | 2004-11-11 | Elisabetta Bianchi | Influenza virus vaccine |
-
2005
- 2005-12-21 WO PCT/US2005/046662 patent/WO2006069262A2/en active Application Filing
- 2005-12-21 BR BRPI0519705-8A patent/BRPI0519705A2/pt not_active IP Right Cessation
- 2005-12-21 JP JP2007547054A patent/JP2008524261A/ja active Pending
- 2005-12-21 AU AU2005319141A patent/AU2005319141B8/en not_active Ceased
- 2005-12-21 NZ NZ556004A patent/NZ556004A/en not_active IP Right Cessation
- 2005-12-21 CA CA002593746A patent/CA2593746A1/en not_active Abandoned
- 2005-12-21 MX MX2007007586A patent/MX2007007586A/es not_active Application Discontinuation
- 2005-12-21 SG SG201001924-8A patent/SG160424A1/en unknown
- 2005-12-21 EP EP05855253A patent/EP1831259A2/en not_active Withdrawn
-
2010
- 2010-01-07 AU AU2010200048A patent/AU2010200048A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| BRPI0519705A2 (pt) | 2009-03-10 |
| MX2007007586A (es) | 2007-12-10 |
| JP2008524261A (ja) | 2008-07-10 |
| AU2005319141B8 (en) | 2010-03-18 |
| AU2005319141B2 (en) | 2010-02-18 |
| AU2005319141A1 (en) | 2006-06-29 |
| NZ556004A (en) | 2010-05-28 |
| AU2010200048A1 (en) | 2010-01-28 |
| WO2006069262A3 (en) | 2007-02-01 |
| EP1831259A2 (en) | 2007-09-12 |
| WO2006069262A2 (en) | 2006-06-29 |
| CA2593746A1 (en) | 2006-06-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SG160424A1 (en) | Compositions of influenza viral proteins and methods of use thereof | |
| WO2004094466A3 (en) | Recombinant influenza viruses holding a mutation in a transmembrane protein gene | |
| WO2007053188A3 (en) | Production of multivalent virus like particles | |
| CY1119243T1 (el) | Φαρμακοτεχνικες μορφες ανταγωνιστη του vegf | |
| WO2004084805A3 (en) | Acetylated tat polypeptides and methods of use thereof | |
| NZ521396A (en) | Fusion proteins comprising two or more Neisseria polypeptides | |
| DE60329983D1 (de) | Wachsestersynthase-dna-sequenz, protein und verwendungen davon | |
| EA200801798A1 (ru) | Виросомоподобные везикулы, содержащие антигены, производные от gp41 | |
| IL171109A (en) | Glycopagilization methods and proteins / peptides produced by these methods | |
| PL1699822T3 (pl) | Białka fuzyjne IL-7 z częściami przeciwciała, ich otrzymywanie oraz ich zastosowanie | |
| EP2089053A4 (en) | HPV ANTIGEN FUSION PROTEIN VACCINE COMPOUNDS AND ITS USES | |
| WO2003068941A3 (en) | Modulation of immune response by non-peptide binding stress response polypeptides | |
| WO2008134697A3 (en) | Prrsv vaccins based on gp5 proteins | |
| ATE551069T1 (de) | Mucin-fusionspolypeptid-vakzine, zusammensetzungen und ihre verwendung | |
| WO2007078879A3 (en) | Lipopeptide compositions and methods of use thereof | |
| WO2005118813A3 (en) | Nucleic acids, polypeptides, methods of expression, and immunogenic compositions associated with sars corona virus spike protein | |
| DE60139544D1 (de) | Veränderte, fluoreszierende proteine | |
| WO2003032898A3 (en) | Modified human thymic stromal lymphopoietin | |
| EP1742968A4 (en) | IL-13 MUTEIN PROTEINS AND ANTIBODIES, COMPOSITIONS, METHODS AND APPLICATIONS | |
| FR2819810B1 (fr) | Peptides non glycosyles derives de la proteine g du vrs et leur utilisation dans un vaccin | |
| WO2006073422A3 (en) | Activation of natural killer (nk) cells and methods of use | |
| ATE389397T1 (de) | Adjuvante zusammensetzungen | |
| TW200509964A (en) | VP1 of foot-and-mouth disease virus | |
| DK1578772T3 (da) | Cytokiner og cytokinreceptorer med reduceret immunogenicitet | |
| WO2001088137A3 (en) | Human myd88 adapter-like protein and functional fragments thereof |